| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.007 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |